1. Executive Summary |
2. Global Fluorescence Imaging Agents Market Introduction |
2.1. Global Fluorescence Imaging Agents Market - Taxonomy |
2.2. Global Fluorescence Imaging Agents Market - Definitions |
2.2.1. Molecule |
2.2.2. Application |
2.2.3. Region |
3. Global Fluorescence Imaging Agents Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Key Developments |
4. Global Fluorescence Imaging Agents Market By Molecule, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
4.1. Indocyanine Green (Icg) |
4.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.3. Market Opportunity Analysis |
4.2. Fluorescein Sodium |
4.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.3. Market Opportunity Analysis |
4.3. 5-Aminolevulinic Acid (5-Ala) |
4.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.3.3. Market Opportunity Analysis |
4.4. Irdye 800 Cw |
4.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.4.3. Market Opportunity Analysis |
4.5. Hexaminolevulinate |
4.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.5.3. Market Opportunity Analysis |
4.6. Pafolacianine |
4.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.6.3. Market Opportunity Analysis |
5. Global Fluorescence Imaging Agents Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Angiography |
5 1 1 Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Perfusion |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Lymphangiography |
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Cholangiography |
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Oncologic Surgery |
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6. Global Fluorescence Imaging Agents Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. North America |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Europe |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Asia Pacific |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Latin America |
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. MEA |
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Global Fluorescence Imaging Agents Market - Opportunity Analysis Index, By Application, Molecule, and Region, 2024-2030 |
7. North America Fluorescence Imaging Agents Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. Molecule Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.1.1. Indocyanine Green (Icg) |
7.1.2. Fluorescein Sodium |
7.1.3. 5-Aminolevulinic Acid (5-Ala) |
7.1.4. Irdye 800 Cw |
7.1.5. Hexaminolevulinate |
7.1.6. Pafolacianine |
7.2. Application Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.2.1. Angiography |
7.2.2. Perfusion |
7.2.3. Lymphangiography |
7.2.4. Cholangiography |
7.2.5. Oncologic Surgery |
7.3. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.3.1. USA |
7.3.2. Canada |
8. Europe Fluorescence Imaging Agents Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. Molecule Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Indocyanine Green (Icg) |
8.1.2. Fluorescein Sodium |
8.1.3. 5-Aminolevulinic Acid (5-Ala) |
8.1.4. Irdye 800 Cw |
8.1.5. Hexaminolevulinate |
8.1.6. Pafolacianine |
8.2. Application Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Angiography |
8.2.2. Perfusion |
8.2.3. Lymphangiography |
8.2.4. Cholangiography |
8.2.5. Oncologic Surgery |
8.3. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1. Germany |
8.3.2. France |
8.3.3. Italy |
8.3.4. Spain |
8.3.5. UK |
8.3.6. Rest of Europe |
9. Asia Pacific Fluorescence Imaging Agents Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. Molecule Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Indocyanine Green (Icg) |
9.1.2. Fluorescein Sodium |
9.1.3. 5-Aminolevulinic Acid (5-Ala) |
9.1.4. Irdye 800 Cw |
9.1.5. Hexaminolevulinate |
9.1.6. Pafolacianine |
9.2. Application Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Angiography |
9.2.2. Perfusion |
9.2.3. Lymphangiography |
9.2.4. Cholangiography |
9.2.5. Oncologic Surgery |
9.3. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1. China |
9.3.2. Japan |
9.3.3. South Korea |
9.3.4. India |
9.3.5. Rest of APAC |
10. Latin America Fluorescence Imaging Agents Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Molecule Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Indocyanine Green (Icg) |
10.1.2. Fluorescein Sodium |
10.1.3. 5-Aminolevulinic Acid (5-Ala) |
10.1.4. Irdye 800 Cw |
10.1.5. Hexaminolevulinate |
10.1.6. Pafolacianine |
10.2. Application Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Angiography |
10.2.2. Perfusion |
10.2.3. Lymphangiography |
10.2.4. Cholangiography |
10.2.5. Oncologic Surgery |
10.3. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Brazil |
10.3.2. Mexico |
10.3.3. Argentina |
10.3.4. Rest of Latin America |
11. MEA Fluorescence Imaging Agents Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Molecule Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Indocyanine Green (Icg) |
11.1.2. Fluorescein Sodium |
11.1.3. 5-Aminolevulinic Acid (5-Ala) |
11.1.4. Irdye 800 Cw |
11.1.5. Hexaminolevulinate |
11.1.6. Pafolacianine |
11.2. Application Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Angiography |
11.2.2. Perfusion |
11.2.3. Lymphangiography |
11.2.4. Cholangiography |
11.2.5. Oncologic Surgery |
11.3. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1. GCC Countries |
11.3.2. South Africa |
11.3.3. Rest of MEA |
12. Competition Landscape |
12.1. Strategic Dashboard of Top Market Players |
12.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
12.2.1. Samsung Medical Center |
12.2.2. Amgen |
12.2.3. Novartis Pharmaceuticals |
12.2.4. Astellas Pharma Global Development, Inc. |
12.2.5. Hoffmann-La Roche |
12.2.6. Quest Medical Imaging B.V. |
12.2.7. Stryker |
12.2.8. KARL STORZ SE & Co. KG |
12.2.9. Olympus |
12.2.10. Hamamatsu Photonics K.K |
12.2.11. Mizuho Medical Co, Ltd. |
12.2.12. Shimadzu Corporation |
12.2.13. Leica Microsystems |
12.2.14. Medtronic (Visionsense) |
12.2.15. PerkinElmer, Inc. |
12.2.16. Carl Zeiss Meditec |
12.2.17. Fluoptics |
13. Research Methodology |
14. Key Assumptions and Acronyms |